Remove 2019 Remove Dosage Remove Packaging
article thumbnail

Sustainable pharma packaging: breaking down the barriers to adoption

European Pharmaceutical Review

For most consumers, product packaging represents their first impression of a brand and its sustainability credentials. But how is this push shaping the pharma packaging market and what are the key changes we can expect to see? For many, aesthetic appeal and user experience top the list of priorities when it comes to packaging design.

article thumbnail

Victoza generic availability, cost, and dosage

The Checkup by Singlecare

Since 2010, Victoza has had more FDA approvals, including one in 2019, where it was approved for pediatric patients with type 2 diabetes. Both generic versions contain the same active ingredient, dosage strengths, and delivery method as the original Victoza, so they should work as effectively. milligrams injection per day.

Dosage 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

First multiple sclerosis biosimilar approved in Europe

European Pharmaceutical Review

Sandoz entered into a global commercialization agreement for biosimilar natalizumab with Polpharma Biologics in 2019. The regulatory package submitted to the EC included evidence derived extensive analytical characterisation. Sandoz has the rights to commercialise and distribute it in all markets under the deal.

article thumbnail

EMA Annex 1 Q&A discusses bioburden considerations

European Pharmaceutical Review

Update January 2019: This Q&A has been superseded by the Guideline on The Sterilisation of the medicinal product, active substance, excipient and primary container. This is in line with the notes for guidance on manufacture of the finished dosage form (CPMP/QWP/486/95 and EMEA/CVMP/126/95). What is the maximum bioburden level?

article thumbnail

Are microtaggants the key to making medicines smarter?

pharmaphorum

Many countries have introduced serialisation legislation which requires product identifiers to be affixed to each package to provide traceability throughout the distribution supply chain. However, traceability and security measures focused on the packaging level may not be enough to protect patients. About the author .

article thumbnail

2022 spells change for EU pharmaceutical legislation

European Pharmaceutical Review

However, a Gupta study from 2019 on what companies spend money on when developing new drugs showed that out?of?pocket It is too early to say because we have not seen the whole package of measures yet. Amsterdam: Gupta Strategists; 2019. pocket expenses account for only seven percent of the overall cost of developing drugs.

article thumbnail

Lion’s mane mushroom benefits

The Checkup by Singlecare

There’s no universally recommended dosage amount, so recommended dosage amounts depend on the form of the supplement, the purpose, and the consumer’s age and health. A supplement package may claim it contains lion’s mane mushroom, but it may not specify what part of the mushroom it’s made from. Dr. Cooperman explains.